Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) Short Interest Update

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 11,470,000 shares, a decline of 11.2% from the May 31st total of 12,910,000 shares. Approximately 4.3% of the company’s shares are short sold. Based on an average daily volume of 2,600,000 shares, the days-to-cover ratio is currently 4.4 days.

Institutional Trading of Asensus Surgical

A hedge fund recently raised its stake in Asensus Surgical stock. Virtu Financial LLC lifted its stake in shares of Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 834.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 249,019 shares of the company’s stock after purchasing an additional 222,368 shares during the quarter. Virtu Financial LLC owned about 0.09% of Asensus Surgical worth $57,000 at the end of the most recent reporting period. 9.35% of the stock is owned by hedge funds and other institutional investors.

Asensus Surgical Stock Performance

Shares of Asensus Surgical stock opened at $0.33 on Wednesday. Asensus Surgical has a twelve month low of $0.20 and a twelve month high of $0.65.

Asensus Surgical (NYSEAMERICAN:ASXC) last issued its quarterly earnings results on Tuesday, May 14th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02). The firm had revenue of $1.12 million for the quarter, compared to the consensus estimate of $1.10 million. Asensus Surgical had a negative net margin of 902.25% and a negative return on equity of 184.10%. On average, research analysts predict that Asensus Surgical will post -0.24 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “neutral” rating and issued a $0.35 price objective on shares of Asensus Surgical in a research note on Thursday, May 16th.

About Asensus Surgical

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.